Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells

Liu, Y; Chen, W; Yu, MX; Li, HJ; Cheng, H; Cao, J; Yan, ZL; Shi, M; Zhu, F; Sun, HY; Sang, W; Li, DP; Wu, QY; Chen, C; Zheng, JN; Xu, KL; Li, ZY

Li, ZY (通讯作者),Xuzhou Med Univ, Dept Hematol, Affiliated Hosp, 99 West Huaihai Rd, Xuzhou 221002, Jiangsu, Peoples R China.

TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (2):

Abstract

Chimeric antigen receptor (CAR) T cell therapy has shown unprecedented response rates in patients with relapsed/refractory (R/R) multiple myeloma (MM)......

Full Text Link